Loading…

Interactive effects of oligofructose and obesity predisposition on gut hormones and microbiota in diet‐induced obese rats

Objective Oligofructose (OFS) is a prebiotic that reduces energy intake and fat mass via changes in gut satiety hormones and microbiota. The effects of OFS may vary depending on predisposition to obesity. The aim of this study was to examine the effect of OFS in diet‐induced obese (DIO) and diet‐res...

Full description

Saved in:
Bibliographic Details
Published in:Obesity (Silver Spring, Md.) Md.), 2015-04, Vol.23 (4), p.769-778
Main Authors: Cluny, Nina L., Eller, Lindsay K., Keenan, Catherine M., Reimer, Raylene A., Sharkey, Keith A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4547-9e0c86d3442b9b7bfbeebee5eb091a1b9ba6f9fdf06ec8d1f4f33ab8e9d023933
cites cdi_FETCH-LOGICAL-c4547-9e0c86d3442b9b7bfbeebee5eb091a1b9ba6f9fdf06ec8d1f4f33ab8e9d023933
container_end_page 778
container_issue 4
container_start_page 769
container_title Obesity (Silver Spring, Md.)
container_volume 23
creator Cluny, Nina L.
Eller, Lindsay K.
Keenan, Catherine M.
Reimer, Raylene A.
Sharkey, Keith A.
description Objective Oligofructose (OFS) is a prebiotic that reduces energy intake and fat mass via changes in gut satiety hormones and microbiota. The effects of OFS may vary depending on predisposition to obesity. The aim of this study was to examine the effect of OFS in diet‐induced obese (DIO) and diet‐resistant (DR) rats. Methods Adult, male DIO, and DR rats were randomized to: high‐fat/high‐sucrose (HFS) diet or HFS diet + 10% OFS for 6 weeks. Body composition, food intake, gut microbiota, plasma gut hormones, and cannabinoid CB1 receptor expression in the nodose ganglia were measured. Results OFS reduced body weight, energy intake, and fat mass in both phenotypes (P 
doi_str_mv 10.1002/oby.21017
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1667960977</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1667960977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4547-9e0c86d3442b9b7bfbeebee5eb091a1b9ba6f9fdf06ec8d1f4f33ab8e9d023933</originalsourceid><addsrcrecordid>eNp10c1KHTEYBuAgSo_VLryBEnDTLs4xmcxMJkuVVg8IbhR0NeTny2lkZnJMMi2HbnoJvUavxOioC0H4ID88vCS8CB1QsqCEFEdebRYFJZRvoV0qGJlzJm623_YNnaHPMd4RUtakop_QrKiaghRVvYv-LocEQerkfgMGa0GniL3FvnMrb8Ook4-A5WCwVxBd2uB1AOPi2ueD8wPOsxoT_uVD7weIz7R3OnjlfJLYDdg4SA___rvBjBqmHMBBpriPdqzsInx5WffQ9c8fV6fn84vLs-Xp8cVcl1XJ5wKIbmrDyrJQQnFlFUCeChQRVNJ8J2srrLGkBt0YakvLmFQNCEMKJhjbQ9-m3HXw9yPE1PYuaug6OYAfY0vrmouaCM4zPXxH7_wYhvy6rHjDC0Z4mdX3SeVvxhjAtuvgehk2LSXtUyNtbqR9biTbry-Jo-rBvMnXCjI4msAf18Hm46T28uR2inwELg6ZVA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1678723074</pqid></control><display><type>article</type><title>Interactive effects of oligofructose and obesity predisposition on gut hormones and microbiota in diet‐induced obese rats</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Cluny, Nina L. ; Eller, Lindsay K. ; Keenan, Catherine M. ; Reimer, Raylene A. ; Sharkey, Keith A.</creator><creatorcontrib>Cluny, Nina L. ; Eller, Lindsay K. ; Keenan, Catherine M. ; Reimer, Raylene A. ; Sharkey, Keith A.</creatorcontrib><description>Objective Oligofructose (OFS) is a prebiotic that reduces energy intake and fat mass via changes in gut satiety hormones and microbiota. The effects of OFS may vary depending on predisposition to obesity. The aim of this study was to examine the effect of OFS in diet‐induced obese (DIO) and diet‐resistant (DR) rats. Methods Adult, male DIO, and DR rats were randomized to: high‐fat/high‐sucrose (HFS) diet or HFS diet + 10% OFS for 6 weeks. Body composition, food intake, gut microbiota, plasma gut hormones, and cannabinoid CB1 receptor expression in the nodose ganglia were measured. Results OFS reduced body weight, energy intake, and fat mass in both phenotypes (P &lt; 0.05). Select gut microbiota differed in DIO versus DR rats (P &lt; 0.05), the differences being eliminated by OFS. OFS did not modify plasma ghrelin or CB1 expression in nodose ganglia, but plasma levels of GIP were reduced and PYY were elevated (P &lt; 0.05) by OFS. Conclusions OFS was able to reduce body weight and adiposity in both prone and resistant obese phenotypes. OFS‐induced changes in gut microbiota profiles in DIO and DR rats, along with changes in gut hormone levels, likely contribute to the sustained lower body weights.</description><identifier>ISSN: 1930-7381</identifier><identifier>EISSN: 1930-739X</identifier><identifier>DOI: 10.1002/oby.21017</identifier><identifier>PMID: 25820256</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adiposity - drug effects ; Animals ; Body Composition - drug effects ; Body Weight - drug effects ; Diet ; Dietary Fats - administration &amp; dosage ; Eating - drug effects ; Gastrointestinal Hormones - metabolism ; Ghrelin ; Glucagon-Like Peptide 1 - metabolism ; Hormones ; Male ; Microbiota ; Obesity ; Obesity - drug therapy ; Obesity - metabolism ; Oligosaccharides - administration &amp; dosage ; Prebiotics ; Rats ; Rats, Sprague-Dawley ; Rodents ; Satiation ; Weight control</subject><ispartof>Obesity (Silver Spring, Md.), 2015-04, Vol.23 (4), p.769-778</ispartof><rights>2015 The Obesity Society</rights><rights>2015 The Obesity Society.</rights><rights>Copyright Blackwell Publishing Ltd. Apr 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4547-9e0c86d3442b9b7bfbeebee5eb091a1b9ba6f9fdf06ec8d1f4f33ab8e9d023933</citedby><cites>FETCH-LOGICAL-c4547-9e0c86d3442b9b7bfbeebee5eb091a1b9ba6f9fdf06ec8d1f4f33ab8e9d023933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25820256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cluny, Nina L.</creatorcontrib><creatorcontrib>Eller, Lindsay K.</creatorcontrib><creatorcontrib>Keenan, Catherine M.</creatorcontrib><creatorcontrib>Reimer, Raylene A.</creatorcontrib><creatorcontrib>Sharkey, Keith A.</creatorcontrib><title>Interactive effects of oligofructose and obesity predisposition on gut hormones and microbiota in diet‐induced obese rats</title><title>Obesity (Silver Spring, Md.)</title><addtitle>Obesity (Silver Spring)</addtitle><description>Objective Oligofructose (OFS) is a prebiotic that reduces energy intake and fat mass via changes in gut satiety hormones and microbiota. The effects of OFS may vary depending on predisposition to obesity. The aim of this study was to examine the effect of OFS in diet‐induced obese (DIO) and diet‐resistant (DR) rats. Methods Adult, male DIO, and DR rats were randomized to: high‐fat/high‐sucrose (HFS) diet or HFS diet + 10% OFS for 6 weeks. Body composition, food intake, gut microbiota, plasma gut hormones, and cannabinoid CB1 receptor expression in the nodose ganglia were measured. Results OFS reduced body weight, energy intake, and fat mass in both phenotypes (P &lt; 0.05). Select gut microbiota differed in DIO versus DR rats (P &lt; 0.05), the differences being eliminated by OFS. OFS did not modify plasma ghrelin or CB1 expression in nodose ganglia, but plasma levels of GIP were reduced and PYY were elevated (P &lt; 0.05) by OFS. Conclusions OFS was able to reduce body weight and adiposity in both prone and resistant obese phenotypes. OFS‐induced changes in gut microbiota profiles in DIO and DR rats, along with changes in gut hormone levels, likely contribute to the sustained lower body weights.</description><subject>Adiposity - drug effects</subject><subject>Animals</subject><subject>Body Composition - drug effects</subject><subject>Body Weight - drug effects</subject><subject>Diet</subject><subject>Dietary Fats - administration &amp; dosage</subject><subject>Eating - drug effects</subject><subject>Gastrointestinal Hormones - metabolism</subject><subject>Ghrelin</subject><subject>Glucagon-Like Peptide 1 - metabolism</subject><subject>Hormones</subject><subject>Male</subject><subject>Microbiota</subject><subject>Obesity</subject><subject>Obesity - drug therapy</subject><subject>Obesity - metabolism</subject><subject>Oligosaccharides - administration &amp; dosage</subject><subject>Prebiotics</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Rodents</subject><subject>Satiation</subject><subject>Weight control</subject><issn>1930-7381</issn><issn>1930-739X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp10c1KHTEYBuAgSo_VLryBEnDTLs4xmcxMJkuVVg8IbhR0NeTny2lkZnJMMi2HbnoJvUavxOioC0H4ID88vCS8CB1QsqCEFEdebRYFJZRvoV0qGJlzJm623_YNnaHPMd4RUtakop_QrKiaghRVvYv-LocEQerkfgMGa0GniL3FvnMrb8Ook4-A5WCwVxBd2uB1AOPi2ueD8wPOsxoT_uVD7weIz7R3OnjlfJLYDdg4SA___rvBjBqmHMBBpriPdqzsInx5WffQ9c8fV6fn84vLs-Xp8cVcl1XJ5wKIbmrDyrJQQnFlFUCeChQRVNJ8J2srrLGkBt0YakvLmFQNCEMKJhjbQ9-m3HXw9yPE1PYuaug6OYAfY0vrmouaCM4zPXxH7_wYhvy6rHjDC0Z4mdX3SeVvxhjAtuvgehk2LSXtUyNtbqR9biTbry-Jo-rBvMnXCjI4msAf18Hm46T28uR2inwELg6ZVA</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Cluny, Nina L.</creator><creator>Eller, Lindsay K.</creator><creator>Keenan, Catherine M.</creator><creator>Reimer, Raylene A.</creator><creator>Sharkey, Keith A.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201504</creationdate><title>Interactive effects of oligofructose and obesity predisposition on gut hormones and microbiota in diet‐induced obese rats</title><author>Cluny, Nina L. ; Eller, Lindsay K. ; Keenan, Catherine M. ; Reimer, Raylene A. ; Sharkey, Keith A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4547-9e0c86d3442b9b7bfbeebee5eb091a1b9ba6f9fdf06ec8d1f4f33ab8e9d023933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adiposity - drug effects</topic><topic>Animals</topic><topic>Body Composition - drug effects</topic><topic>Body Weight - drug effects</topic><topic>Diet</topic><topic>Dietary Fats - administration &amp; dosage</topic><topic>Eating - drug effects</topic><topic>Gastrointestinal Hormones - metabolism</topic><topic>Ghrelin</topic><topic>Glucagon-Like Peptide 1 - metabolism</topic><topic>Hormones</topic><topic>Male</topic><topic>Microbiota</topic><topic>Obesity</topic><topic>Obesity - drug therapy</topic><topic>Obesity - metabolism</topic><topic>Oligosaccharides - administration &amp; dosage</topic><topic>Prebiotics</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Rodents</topic><topic>Satiation</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cluny, Nina L.</creatorcontrib><creatorcontrib>Eller, Lindsay K.</creatorcontrib><creatorcontrib>Keenan, Catherine M.</creatorcontrib><creatorcontrib>Reimer, Raylene A.</creatorcontrib><creatorcontrib>Sharkey, Keith A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity (Silver Spring, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cluny, Nina L.</au><au>Eller, Lindsay K.</au><au>Keenan, Catherine M.</au><au>Reimer, Raylene A.</au><au>Sharkey, Keith A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interactive effects of oligofructose and obesity predisposition on gut hormones and microbiota in diet‐induced obese rats</atitle><jtitle>Obesity (Silver Spring, Md.)</jtitle><addtitle>Obesity (Silver Spring)</addtitle><date>2015-04</date><risdate>2015</risdate><volume>23</volume><issue>4</issue><spage>769</spage><epage>778</epage><pages>769-778</pages><issn>1930-7381</issn><eissn>1930-739X</eissn><abstract>Objective Oligofructose (OFS) is a prebiotic that reduces energy intake and fat mass via changes in gut satiety hormones and microbiota. The effects of OFS may vary depending on predisposition to obesity. The aim of this study was to examine the effect of OFS in diet‐induced obese (DIO) and diet‐resistant (DR) rats. Methods Adult, male DIO, and DR rats were randomized to: high‐fat/high‐sucrose (HFS) diet or HFS diet + 10% OFS for 6 weeks. Body composition, food intake, gut microbiota, plasma gut hormones, and cannabinoid CB1 receptor expression in the nodose ganglia were measured. Results OFS reduced body weight, energy intake, and fat mass in both phenotypes (P &lt; 0.05). Select gut microbiota differed in DIO versus DR rats (P &lt; 0.05), the differences being eliminated by OFS. OFS did not modify plasma ghrelin or CB1 expression in nodose ganglia, but plasma levels of GIP were reduced and PYY were elevated (P &lt; 0.05) by OFS. Conclusions OFS was able to reduce body weight and adiposity in both prone and resistant obese phenotypes. OFS‐induced changes in gut microbiota profiles in DIO and DR rats, along with changes in gut hormone levels, likely contribute to the sustained lower body weights.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>25820256</pmid><doi>10.1002/oby.21017</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1930-7381
ispartof Obesity (Silver Spring, Md.), 2015-04, Vol.23 (4), p.769-778
issn 1930-7381
1930-739X
language eng
recordid cdi_proquest_miscellaneous_1667960977
source Wiley-Blackwell Read & Publish Collection
subjects Adiposity - drug effects
Animals
Body Composition - drug effects
Body Weight - drug effects
Diet
Dietary Fats - administration & dosage
Eating - drug effects
Gastrointestinal Hormones - metabolism
Ghrelin
Glucagon-Like Peptide 1 - metabolism
Hormones
Male
Microbiota
Obesity
Obesity - drug therapy
Obesity - metabolism
Oligosaccharides - administration & dosage
Prebiotics
Rats
Rats, Sprague-Dawley
Rodents
Satiation
Weight control
title Interactive effects of oligofructose and obesity predisposition on gut hormones and microbiota in diet‐induced obese rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A25%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interactive%20effects%20of%20oligofructose%20and%20obesity%20predisposition%20on%20gut%20hormones%20and%20microbiota%20in%20diet%E2%80%90induced%20obese%20rats&rft.jtitle=Obesity%20(Silver%20Spring,%20Md.)&rft.au=Cluny,%20Nina%20L.&rft.date=2015-04&rft.volume=23&rft.issue=4&rft.spage=769&rft.epage=778&rft.pages=769-778&rft.issn=1930-7381&rft.eissn=1930-739X&rft_id=info:doi/10.1002/oby.21017&rft_dat=%3Cproquest_cross%3E1667960977%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4547-9e0c86d3442b9b7bfbeebee5eb091a1b9ba6f9fdf06ec8d1f4f33ab8e9d023933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1678723074&rft_id=info:pmid/25820256&rfr_iscdi=true